Common Contracts
5 similar Executive Severance Benefits Agreement contracts by Five Prime Therapeutics Inc
Executive Severance Benefits AgreementExecutive Severance Benefits Agreement • February 26th, 2019 • Five Prime Therapeutics Inc • Pharmaceutical preparations • California
This Executive Severance Benefits Agreement (this “Agreement”), effective as of November 26, 2018 (the “Effective Date”), is between David Smith (“Executive”) and Five Prime Therapeutics, Inc. (“FivePrime”). This Agreement is intended to provide Executive with certain compensation and benefits in the event that Executive is subject to certain qualifying terminations of employment. Certain capitalized terms used in this Agreement are defined in Article 6.
Executive Severance Benefits AgreementExecutive Severance Benefits Agreement • February 26th, 2019 • Five Prime Therapeutics Inc • Pharmaceutical preparations • California
This Executive Severance Benefits Agreement (this “Agreement”), effective as of September 5, 2017 (the “Effective Date”), is between Bryan Irving, Ph.D. (“Executive”) and Five Prime Therapeutics, Inc. (“FivePrime”). This Agreement is intended to provide Executive with certain compensation and benefits in the event that Executive is subject to certain qualifying terminations of employment. Certain capitalized terms used in this Agreement are defined in Article 6.
Executive Severance Benefits AgreementExecutive Severance Benefits Agreement • February 27th, 2018 • Five Prime Therapeutics Inc • Pharmaceutical preparations • California
This Executive Severance Benefits Agreement (this “Agreement”), effective as of March 20, 2017 (the “Effective Date”), is between Helen Collins (“Executive”) and Five Prime Therapeutics, Inc. (“FivePrime”). This Agreement is intended to provide Executive with certain compensation and benefits in the event that Executive is subject to certain qualifying terminations of employment. Certain capitalized terms used in this Agreement are defined in Article 6.
Executive Severance Benefits AgreementExecutive Severance Benefits Agreement • February 24th, 2017 • Five Prime Therapeutics Inc • Pharmaceutical preparations • California
This Executive Severance Benefits Agreement (this “Agreement”), effective as of February 1, 2016 (the “Effective Date”), between Kevin Paul Baker, Ph.D. (“Executive”) and Five Prime Therapeutics, Inc. (“FivePrime”). This Agreement is intended to provide Executive with certain compensation and benefits in the event that Executive is subject to certain qualifying terminations of employment. Certain capitalized terms used in this Agreement are defined in Article 6.
Executive Severance Benefits AgreementExecutive Severance Benefits Agreement • February 24th, 2017 • Five Prime Therapeutics Inc • Pharmaceutical preparations • California
